recent articles
OptraSCAN: AI-Powered Cytology Platform Expands Access and Accuracy for Cervical Cancer Screening Across Asia—Aligned with WHO’s 90-70-90 Elimination Goals SINGAPORE, August 5, 2025 /EINPresswire.com/ -- OptraSCAN, a global leader in...
Nijmegen, the Netherlands – Aiosyn, a pioneering innovator in AI-powered pathology software for cancer and kidney disease, has introduced a new enhancement to its automated quality control (QC) solution, AiosynQC. The latest...
January 16, 2024
Digital pathology is just pathology, but does it matter anymore?
- Advocacy
- Anatomic Pathology
- Artificial Intelligence
- Clinical Laboratories
- Current Affairs
- Data Management
- Digital Pathology News
- Education
- FDA Approval
- General Healthcare News
- Health Technology Collaboration
- Laboratory Management & Operations
- Microscopy
- Molecular Pathology
- Pathology News
- Personal
- Science
- TeleHealth
- Web/Tech
- Whole slide
Since the 1990s, many innovators to Fortune 500 and Fortune 50 companies have worked to make digital pathology a reality. While not mainstream and perhaps less than 10% of US based pathology groups have any serious implementations of digital...
© 2023 Tissuepathology.com. All rights reserved. Millennial Consulting. | Web Design by Zealth Digital Marketing